Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma: Erratum

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797557/
https://www.ncbi.nlm.nih.gov/pubmed/35089237
http://dx.doi.org/10.1097/MD.0000000000028714
_version_ 1784641580404047872
collection PubMed
description
format Online
Article
Text
id pubmed-8797557
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-87975572022-01-31 Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma: Erratum Medicine (Baltimore) Erratum Lippincott Williams & Wilkins 2022-01-28 /pmc/articles/PMC8797557/ /pubmed/35089237 http://dx.doi.org/10.1097/MD.0000000000028714 Text en Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Erratum
Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma: Erratum
title Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma: Erratum
title_full Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma: Erratum
title_fullStr Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma: Erratum
title_full_unstemmed Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma: Erratum
title_short Neoadjuvant chemotherapy reduces the expression rates of ER, PR, HER2, Ki67, and P53 of invasive ductal carcinoma: Erratum
title_sort neoadjuvant chemotherapy reduces the expression rates of er, pr, her2, ki67, and p53 of invasive ductal carcinoma: erratum
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797557/
https://www.ncbi.nlm.nih.gov/pubmed/35089237
http://dx.doi.org/10.1097/MD.0000000000028714

Ejemplares similares